5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.

Company

Nov. 15

Weekly Gain

Organovo  (NYSEMKT: ONVO  )

$12.50

52%

Ellie Mae  (NYSE: ELLI  )

$27.62

20%

Kandi (NASDAQ: KNDI  )

$7.04

14%

Arena Pharmaceuticals  (NASDAQ: ARNA  )

$5.46

14%

SINA  (NASDAQ: SINA  )

$85.05

12%

Source: Barron's.

Let's start with Organovo. The 3-D bioprinting upstart was profiled in this column last week after ratting off three consecutive weeks of 10% gains. You don't see that every day. Well, it capped off that impressive three-week streak by soaring 52% this past week.

Organovo's goal is to "print" human tissue that can be used for drug testing. It offered up an encouraging business update in which it confirmed that it's still on track to release its first commercial product -- a liver toxicity assay test -- next year.

Ellie Mae bounce back after buyout speculation picked up. Inside Mortgage Finance reported that three bidders were offering as much as $1.1 billion for the mortgage software specialist. Takeover buzz began building this summer, but investors cooled on Ellie Mae as mortgage originations and refinance applications began to slip.

Kandi Technologies moved higher after the Chinese maker of electric vehicles announced that it will soon deliver the first group of four-passenger pure electric sedans that will be part of a public electric-vehicle sharing systen in Hangzhou.

Arena Pharmaceuticals continued to move higher after expanding a marketing relationship for its weight-loss drug during the prior week. It then capped off the week with WallachBeth initiating coverage with a "buy" rating.

Finally we have SINA moving higher after posting well-received quarterly results. SINA cranked out an adjusted profit of $0.42 a share on $184.6 million in revenue. Analysts were holding out for earnings of just $0.32 per share on $178.6 million in revenue.

Keep the good vibes coming
Tired of watching your stocks creep up year after year at a glacial pace? Motley Fool co-founder David Gardner, founder of the world's No. 1 growth-stock newsletter, has developed a unique strategy for uncovering truly wealth-changing stock picks. And he wants to share it, along with a few of his favorite growth stock superstars, with you! It's a special 100% free report called "6 Picks for Ultimate Growth." So stop settling for index-hugging gains, and click here for instant access to a whole new game plan of stock picks to help power your portfolio.


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2731504, ~/Articles/ArticleHandler.aspx, 4/18/2014 2:46:09 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement